David Henn

David Henn has extensive experience in the cannabis industry, beginning in 2021 as the CEO of Semdor Pharma Group. From 2016 to 2021, they were the CEO and Founder of Cannamedical Pharma GmbH, where they were a key driver of the Company's growth, on-going vision and structuring. From 2016 to 2015, they were a Partner at Cannapreneur Consultig, where they directed client services on multiple engagements to structure and develop timelines, performance risk assessments and strategy planning for Euroepan Cannabis realated Start-ups. From 2015 to 2012, they were the CEO of Cannaseur (Exit). From 2012 to 2013, they were an Institutional Derivative Sales at LBBW Landesbank Baden-Württemberg, and from 2013 to 2016 they were a Derivative Trading at Deutsche Bank.

David Henn completed their Bachelor's degree in International Business and Financial Management from CBS International Business School in 2014. David then went on to pursue a Master's degree in the same field at CBS International Business School, which they completed in 2016.